✦ LIBER ✦

Impact of Abciximab in Elderly Patients with High-Risk Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

✍ Scribed by Dr Allan Zeeberg Iversen, Soeren Galatius, Sune Pedersen, Jan K. Madsen…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of Bleeding on Outcomes in Patien

✍ D. Stub; N. Andrianopoulos; A. Brennan; P. Loane; R. Sharma; A. Ajani; G. New; A 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 108 KB

The early percutaneous coronary interven

✍ Huang, Xiong ;Cao, Xuebin ;Zhang, Gang 📂 Article 📅 2008 🏛 Higher Education Press and Springer 🌐 English ⚖ 58 KB

Comparison of abciximab with “high-dose”

✍ Athula P. Gunasekara; Darren L. Walters; Con N. Aroney 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 109 KB

High-dose tirofiban vs abciximab in acut

✍ Mohammed A. Balghith; Sharif Zain; Omaimah Alaomary 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Prasugrel versus clopidogrel in acute co

✍ Deepak L. Bhatt 📂 Article 📅 2008 🏛 Current Science Inc. 🌐 English ⚖ 161 KB

Troponin ratio and risk stratification i

✍ Natale Daniele Brunetti; Donato Quagliara; Matteo Di Biase 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 493 KB